[Federal Register Volume 82, Number 82 (Monday, May 1, 2017)]
[Notices]
[Pages 20341-20343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08705]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-17AW]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written

[[Page 20342]]

comments and/or suggestions regarding the items contained in this 
notice should be directed to the Attention: CDC Desk Officer, Office of 
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this 
notice.

Proposed Project

    Assessment of Targeted Training and Technical Assistance (TTA) 
Efforts on the Implementation of Comprehensive Cancer Control--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention's (CDC) National 
Comprehensive Cancer Control Program (NCCCP) has been a primary funder 
for state and community-based cancer control interventions since its 
inception in the late 1990s. In addition, CDC's Office on Smoking and 
Health (OSH) also has worked to build state health department 
infrastructure and capacity to conduct coordinated comprehensive 
tobacco prevention and control activities which contribute to cancer 
health outcomes through the provision of funding to state health 
departments and local partners through the Nation State Based Tobacco 
Control Program (NSTB).
    In striving to build capacity and maximize the impact of CDC's 
funded programs, CDC has focused on developing and implementing 
innovative programs to enhance the training and technical assistance 
(TTA) delivered to NCCCP and NSBT grantee programs. CDC funds 10 
organizations under two cooperative agreements: The Consortium of 
National Networks to Impact Populations Experiencing Tobacco-Related 
and Cancer Health Disparities (DP13-1314), and National Support to 
Enhance Implementation of Comprehensive Cancer Control Activities 
(DP13-1315). Under these cooperative agreements, DP13-1314 and DP13-
1315 awardees provide TTA to state NCCCP and NSBT grantees to support 
local implementation of high-impact public health strategies. Using two 
different TTA models, DP13-1314 and DP13-1315 aim to impact both short- 
and long-term outcomes on the awardee, NCCCP program, and population 
levels.
    CDC proposes to conduct an assessment of the DP13-1314 and DP13-
1315 cooperative agreements to: (1) Increase CDC's understanding of the 
TTA provided to NCCCP and NSTB grantees across both cooperative 
agreements, (2) help identify the extent to which core elements of the 
TTA were administered, and (3) determine the elements of TTA across 
both cooperative agreements that show promise for improving NCCCP and 
NSTB capacity. There are no other data collection efforts currently 
underway to assess implementation of the two TTA models or their 
perceived effectiveness.
    This information collection request will involve three 
complementary data collection efforts: (1) Case studies of DP13-1314 
and DP13-1315 awardees (consisting of interviews with DP13-1314 and 
DP13-1315 program managers/directors, evaluators, and partners); (2) a 
cross-sectional web-based survey administered to NCCCP and NSBT program 
directors, coalition members, and partners; and (3) in-depth interviews 
with selected NCCCP and NSBT program directors, staff, coalition 
members, and partners who received a high volume of TTA from one or 
more of the DP13-1314 and DP13-1315 awardees. The case studies will be 
used to explore how DP13-1314 and DP13-1315 awardees are implementing 
their respective cooperative agreements and administering TTA to NCCCP 
and NSBT grantees; the factors that affect the implementation of 
specific TTA components; and the extent to which each cooperative 
agreement was able to achieve planned short-term outcomes. The Web-
based survey will inform CDC's understanding of the reach of DP13-1314 
and DP13-1315 TTA efforts; elicit information from NCCCP and/or NSBT 
programs and coalitions about the TTA received, including type, dosage, 
frequency and format; and assess the perceptions of the effectiveness 
of the TTA provided in building capacity to achieve intended outcomes. 
The in-depth interviews with ``high-volume'' TTA users will facilitate 
an in-depth exploration of the type and quality of TTA activities 
received; perceived quality of TTA and its contributions to NCCCP and 
NSBT grantee program implementation, and achievement of CDC priorities 
and goals.
    CDC will use findings from the assessment to inform development of 
future TTA efforts that utilize the core elements across the two models 
to more effectively and efficiently support NCCCP's partner 
organizations.
    OMB approval is requested for 2 years. Participation is voluntary 
and respondents will not receive incentives for participation. There 
are no costs to respondents other than their time. The total estimated 
annualized burden hours are 231.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
DP13-1314 and DP13-1315 Awardee         Worksheet for                          5               1               1
 Organizations.                          Identifying Case Study
                                         Interviewees.
DP13-1314 Program Directors/Managers..  Case Study Interview                   4               1             1.5
                                         Guide for DP13-1314
                                         Program Directors/
                                         Managers.
                                        Case Study Follow-Up                   4               1               1
                                         Interview Guide for
                                         DP13-1314 Program
                                         Directors/Managers.
DP13-1315 Directors/Managers..........  Case Study Interview                   1               1             1.5
                                         Guide for DP1-1315
                                         Program Directors/
                                         Managers.
                                        Case Study Follow-Up                   1               1               1
                                         Interview Guide for DP1-
                                         1315 Program Directors/
                                         Managers.
DP13-1314 Evaluators..................  Case Study Interview                   4               1               1
                                         Guide for DP1-1314
                                         Evaluators.
DP13-1315 Evaluators..................  Case Study Interview                   1               1               1
                                         Guide for DP1-1315
                                         Evaluators.
DP13-1314 Partners....................  Case Study Interview                   8               1               1
                                         Guide for DP1-1314
                                         Partners.

[[Page 20343]]

 
DP13-1315 Partners....................  Case Study Interview                   2               1               1
                                         Guide for DP1-1315
                                         Partners.
NCCCP and NSBT Program Directors,       Web-based survey........             780               1           15/60
 Staff, Coalition Members, and
 Partners.
NCCCP and NSBT Program Directors,       In-Depth Interview Guide               5               1             0.5
 Staff, Coalition Members, and
 Partners.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-08705 Filed 4-28-17; 8:45 am]
 BILLING CODE 4163-18-P